J. Gajewski

发表

Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.

N. Ueno, K. Cleary, K. van Besien, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

N. Ueno, A. Anagnostopoulos, D. Weber, 2002, Bone Marrow Transplantation.

Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria

R. Paquette, P. Rosen, L. Kunkel, 1997, British journal of haematology.

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

E. Estey, M. Andreeff, N. Ueno, 2001, American journal of hematology.

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

J. Wingard, B. Andersson, H. Fernandez, 2000, Bone Marrow Transplantation.

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

P. Thall, M. Andreeff, N. Ueno, 2001, Blood.

Primary refractory and relapsed adult acute lymphoblastic leukemia

Terry L. Smith, J. Cortes, S. Pierce, 1999, Cancer.

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia

M. Territo, G. Schiller, Stephen S. Nimer, 1993, American journal of hematology.

Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high‐dose intravenous immunoglobulin

R. Champlin, I. Khouri, D. Przepiorka, 1996, American journal of hematology.

Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation.

M. Talpaz, R. Champlin, A. Shimoni, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

S. Feig, L. Valentino, E. Landaw, 1994, Cell transplantation.

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

S. Nimer, M. Territo, R. Champlin, 1992, Blood.

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

S. Nimer, M. Territo, J. Berenson, 1994, Bone marrow transplantation.

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

S. Vollset, S. Nimer, G. Schiller, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

S. Nimer, M. Territo, R. Champlin, 1993, Leukemia & lymphoma.

Survival outcome among 54 intubated pediatric bone marrow transplant patients

S. Feig, P. Bellamy, E. Landaw, 1994, Critical care medicine.

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

M. Territo, R. Champlin, M. Lee, 1994, Leukemia & lymphoma.

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

S. Nimer, M. Territo, G. Schiller, 1992 .

15 Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease

B. Andersson, D. Couriel, R. Champlin, 2003 .

Outcome after allogeneic bone marrow transplant for leukemia in older adults.

A A Rimm, A. Rimm, M. Horowitz, 1993, JAMA.

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

N. Ueno, B. Andersson, M. Keating, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

J. Hansen, P. Beatty, R. Champlin, 1993, The New England journal of medicine.

P. Beatty, C. Anasetti, J. Gajewski, 1993, Blood.

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

H. Kantarjian, A. Deisseroth, B. Andersson, 1996, The American journal of medicine.

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

S. Nimer, M. Territo, G. Schiller, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.

H. Kantarjian, F. Cabanillas, M. Albitar, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.

R. Collins, H. Deeg, M. Territo, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

S. Feig, J. Giorgi, R. Champlin, 1990, Blood.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

M. Munsell, N. Ueno, B. Andersson, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.

S. Nimer, R. Champlin, K. Hirji, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy versus transplants for acute myelogenous leukemia in second remission.

J. Klein, M. Oken, R. Gray, 1996, Leukemia.

P. Beatty, C. Anasetti, J. Gajewski, 1993, Blood.

Treatment of acute myelogenous leukemia in the elderly.

D. Golde, R. Champlin, J. Gajewski, 1989, Seminars in oncology.